CSS
EVH icon

Cubist Systematic Strategies’s Evolent Health EVH Stock Holding History

Cubist Systematic Strategies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,100
Closed -$682K – 3136
2024
Q3 		$682K Buy
+24,100
New +$621K ﹤0.01% 2063

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cubist Systematic Strategies's EVH Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Evolent Health (EVH) in Q3 2025: 421,387 shares worth $3.56M. The stake represents 0.02% of the portfolio and ranks #1199 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in EVH as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in EVH in Q3 2016 and has held it in 30 quarters since. The position peaked at $10.4M in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Cubist Systematic Strategies held 421,387 shares of Evolent Health worth $3.56M as of Q3 2025.
  • Evolent Health was a new Cubist Systematic Strategies position in Q3 2025.
  • Evolent Health made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1199 holding.
  • Cubist Systematic Strategies first reported a position in Evolent Health in Q3 2016 and has held it in 30 quarters since.
  • Cubist Systematic Strategies's Evolent Health position peaked at $10.4M in Q1 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.